Ibandronate Sodium

CAS 138844-81-2 3 API suppliersSmall Molecule

Overview

Ibandronate Sodium is a bisphosphonate class drug used to prevent and treat osteoporosis in postmenopausal women. It works by inhibiting osteoclast-mediated bone resorption, thus increasing bone mineral density.

API suppliers (3)

Suppliers of Ibandronate Sodium evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India1Canada1Israel1

2 of 3 hold a GMP certificate on record in the EU or UK registers

Therapeutic areas

OsteoporosisBone Disorders
Verified Supplier Partner

Do you supply Ibandronate Sodium? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.